Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

计划入组 38 人 · 首次发布于 2016 年 6 月 2 日

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

计划入组 124 人 · 首次发布于 2024 年 2 月 8 日

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

计划入组 27 人 · 首次发布于 2020 年 7 月 14 日

SAB-953

SAB-300

SAB-01

SAB Biotherapeutics

United States

SKB BIO-B

China

BIO-RAD

France

SAB Biotherapeutics' SAB-142 Shows Promising Safety Profile in Type 1 Diabetes Trial

SAB Biotherapeutics Completes Phase 1 Enrollment of SAB-142 for Type 1 Diabetes

SAB BIO Secures $175 Million Funding to Advance Type 1 Diabetes Immunotherapy Through Phase 2b Trial